Endpoints exclusive: Bob Nelsen’s Resilience snags Florida CDMO working with the Defense Department on Covid-19 antibody

Resilience has only been in existence for less than six months, but it’s made plenty of moves shortly after debuting with an $800 million IPO. Now, the biotech looking to change drug manufacturing is picking up a Florida CDMO partnered with the Department of Defense on a Covid-19 antibody.


Click to view original post